Skip to main content
SpringerLink
Log in

Capsaicin-Pflaster bei CRPS Typ II

Capsaicin plasters for complex regional pain syndrome type II

  • Leserbriefe
  • Published:
Der Schmerz Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Girtler R, Kloimstein H, Gustorff B (2013) Ausgeprägte Symptomverschlechterung bei CRPS II nach einmaliger Applikation eines hochprozentigen Capsaicin-Pflasters – Ein Fallbericht. Schmerz 27(1):67–67

    Article  PubMed  CAS  Google Scholar 

  2. Gustorff B, Poole C, Kloimstein H et al (2013) Treatment of neuropathic pain with the capsaicin 8 % patch: Quantitative sensory testing (QST) in a prospective observational study identifies potential predictors of response to capsaicin 8 % patch treatment. Scand J Pain 4:138–145

    Article  Google Scholar 

  3. Henrich F, Magerl W, Treede RD, Klein T (2012) Differential role of C- and A-fiber nociceptive afferents in the induction of LTP-like pain plasticity in humans. Poster PT 279, Jahrestagung der EFIC, Mailand 2012

  4. Kennedy WR, Vanhove GF, Lu SP et al (2010) A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers. J Pain 11:579–587

    Article  PubMed  CAS  Google Scholar 

  5. Magerl W, Fuchs PN, Meyer RA, Treede RD (2001) Roles of capsaicin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia. Brain 124(Pt 9):1754–1764

    Article  PubMed  CAS  Google Scholar 

  6. Treede RD, Wagner T, Kern KU et al (2013) Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8 % cutaneous patch in patients with localized neuropathic pain. Curr Med Res Opin 29:527–538

    Article  PubMed  CAS  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. B. Gustorff: Vortrags- und Beratungstätigkeit Astellas. H. Kloimstein: Vortragstätigkeit Astellas. R. Girtler gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Capsaicin-Pflaster bei CRPS Typ II. Schmerz 27, 517–520 (2013). https://doi.org/10.1007/s00482-013-1350-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00482-013-1350-x

Search

Navigation